A detailed history of Fluent Financial, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fluent Financial, LLC holds 29,156 shares of GILD stock, worth $3.37 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
29,156
Holding current value
$3.37 Million
% of portfolio
1.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 03, 2025

BUY
$83.95 - $97.9 $2.45 Million - $2.85 Million
29,156 New
29,156 $2.69 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $145B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Fluent Financial, LLC Portfolio

Follow Fluent Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fluent Financial, LLC with notifications on news.